by Bruce Sylvester – Newly published research suggests that a derivative of DHA (docosahexaenoic acid), found in over-the-counter fish oil supplements, might be used to effectively treat and… read more.
by Bruce Sylvester – The combination of obesity and low vitamin D deficiency appears to cause a greater risk of insulin resistance than either factor alone, researchers reported… read more.
By Bruce Sylvester – In a 3-decade study of adults recruited in the United States, researchers report positive correlations between durations of overall obesity and abdominal obesity and… read more.
By Bruce Sylvester – Chronic obstructive pulmonary disease (COPD) is related to an increased risk of cerebral microbleeds, researchers from the Netherlands reported online on July 19, 2013 in… read more.
Taken from JAMA – by Bruce Sylvester – After analyzing data on nearly 60,000 patients with acute ischemic stroke, researchers report that thrombolytic treatment initiated sooner correlates to… read more.
Taken from the NEJM – by Bruce Sylvester – Three biomarkers in the urine of kidney transplant recipients can be used to diagnose and predict transplant rejection, researchers… read more.
Taken from the BMJ – by Bruce Sylvester – The most common type of eating disorder diagnosed in the UK is not bulimia or anorexia, but, rather, “eating… read more.
Taken from the Lancet – by Bruce Sylvester – High doses of some non-steroidal anti-inflammatory drugs (NSAIDs) increase the risk of major vascular events (non-fatal heart attacks, strokes,… read more.
FDA Highlights by Bruce Sylvester – Lexapro (escitalopram), which is used to treat depression and anxiety, appears to improve a stress-related heart condition in persons with stable coronary… read more.
FDA Highlights by Bruce Sylvester – Researchers report that finasteride appears to reduce alcohol consumption in some men. The results were published online on June 13, 2013 by Alcoholism:… read more.
FDA Highlights by Bruce Sylvester – Bazedoxifene, approved in Europe to treat osteoporosis, appears to stop the growth of breast cancer cells, even in therapy-resistant tumors, researchers from… read more.
by Bruce Sylvester – Patients with an advanced kind of lung cancer and a dysfunctional ALK gene have achieved better outcomes with the targeted investigative therapy crizotinib rather… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
